Rhumbline Advisers Agenus Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$0.53 - $0.93 $12,615 - $22,136	23,803 Added 4.55%	546,623 $317,000
Q4 2023 Feb 08, 2024	BUY	$0.63 - $1.14 $14,885 - $26,934	23,627 Added 4.73%	522,820 $433,000
Q3 2023 Nov 09, 2023	BUY	$1.12 - $1.88 $6,249 - $10,490	5,580 Added 1.13%	499,193 $564,000
Q2 2023 Aug 08, 2023	BUY	$1.31 - $2.04 $119,352 - $185,862	91,109 Added 22.64%	493,613 $789,000
Q1 2023 May 11, 2023	BUY	$1.45 - $2.95 $40,141 - $81,667	27,684 Added 7.39%	402,504 $612,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $40,357 - $64,931	19,979 Added 5.63%	374,820 $900,000
Q3 2022 Nov 10, 2022	BUY	$1.96 - $3.14 $76,365 - $122,340	38,962 Added 12.33%	354,841 $727,000
Q2 2022 Aug 11, 2022	BUY	$1.3 - $2.64 $123,390 - $250,578	94,916 Added 42.96%	315,879 $613,000
Q1 2022 May 12, 2022	BUY	$2.35 - $3.47 $31,945 - $47,171	13,594 Added 6.56%	220,963 $544,000
Q4 2021 Feb 10, 2022	SELL	$2.92 - $5.74 $2,219 - $4,362	-760 Reduced 0.37%	207,369 $668,000
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $38,629 - $51,428	7,757 Added 3.87%	208,129 $1.09 Million
Q2 2021 Aug 05, 2021	BUY	$2.56 - $5.49 $44,843 - $96,168	17,517 Added 9.58%	200,372 $1.1 Million
Q1 2021 May 06, 2021	SELL	$2.69 - $5.25 $33,638 - $65,651	-12,505 Reduced 6.4%	182,855 $497,000
Q4 2020 Feb 10, 2021	BUY	$3.17 - $4.49 $56,891 - $80,582	17,947 Added 10.12%	195,360 $621,000
Q3 2020 Nov 12, 2020	SELL	$2.98 - $5.2 $66,379 - $115,830	-22,275 Reduced 11.15%	177,413 $710,000
Q2 2020 Aug 13, 2020	BUY	$2.29 - $4.24 $141,091 - $261,234	61,612 Added 44.62%	199,688 $785,000
Q1 2020 May 06, 2020	SELL	$1.92 - $4.39 $2,688 - $6,146	-1,400 Reduced 1.0%	138,076 $338,000
Q4 2019 Feb 05, 2020	BUY	$2.41 - $4.4 $2,183 - $3,986	906 Added 0.65%	139,476 $568,000
Q3 2019 Oct 23, 2019	SELL	$2.17 - $3.14 $488 - $706	-225 Reduced 0.16%	138,570 $358,000
Q2 2019 Aug 14, 2019	BUY	$2.53 - $3.04 $52,411 - $62,976	20,716 Added 17.54%	138,795 $416,000
Q1 2019 May 01, 2019	BUY	$2.51 - $3.73 $15,220 - $22,618	6,064 Added 5.41%	118,079 $351,000
Q4 2018 Jan 31, 2019	BUY	$1.59 - $2.66 $59,566 - $99,651	37,463 Added 50.25%	112,015 $267,000
Q3 2018 Nov 07, 2018	SELL	$1.59 - $2.42 $4,968 - $7,562	-3,125 Reduced 4.02%	74,552 $160,000
Q2 2018 Aug 06, 2018	BUY	$2.26 - $4.65 $15,099 - $31,066	6,681 Added 9.41%	77,677 $176,000
Q1 2018 May 02, 2018	SELL	$3.51 - $6.04 $3,457 - $5,949	-985 Reduced 1.37%	70,996 $334,000
Q4 2017 Feb 09, 2018	SELL	$3.26 - $4.78 $48,531 - $71,159	-14,887 Reduced 17.14%	71,981 $235,000
Q3 2017 Nov 06, 2017	BUY	$3.48 - $4.44 $302,300 - $385,693	86,868	86,868 $383,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account